Congenital Myasthenia
Gene: PURA
Treatment with pyridostigmine or salbutamol led to clinical improvement of neuromuscular function in two reported casesCreated: 29 Oct 2025, 6:54 a.m. | Last Modified: 29 Oct 2025, 6:54 a.m.
Panel Version: 1.16
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (OMIM 616158)
PMID:36768582 Three cases with clinical myasthenic features confirmed with electrophysiological studies showing decremental response on repetitive nerve stimulation (RNS)
Sources: LiteratureCreated: 28 Oct 2025, 3:49 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Congenital myasthenia; congenital hypoventilation
Publications
Gene: pura has been classified as Green List (High Evidence).
Phenotypes for gene: PURA were changed from Congenital myasthenia; congenital hypoventilation to Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties (OMIM 616158)
Gene: pura has been classified as Green List (High Evidence).
gene: PURA was added gene: PURA was added to Congenital Myasthenia. Sources: Literature Mode of inheritance for gene: PURA was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: PURA were set to 36768582 Phenotypes for gene: PURA were set to Congenital myasthenia; congenital hypoventilation Review for gene: PURA was set to GREEN